via CCSVI in Multiple Sclerosis: "In the news today--a Citizen's Petition to the FDA, asking them to refrain from approving any more MS treatments until they have been reviewed by advisory committees. The petition includes serious safety problems with Tysabri, Gilenya and other MS medications which were identified after they went to market, and cautions approval of BG 12. (Irony here, the petition was filed by Teva) http://freepdfhosting.com/efaf2ebf45.pdf" source: https://www.facebook.com/permalink.php?story_fbid=532531920098053&id=110796282297